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NASAL PARAGANGLIOMA: A CASE REPORT
M Scott,' D S Brooker,2 R I Davis'
1. Departments ofPathology, RoyalGroupofHospitals,
Belfast.
2. Otorhinolaryngology, Royal Group of Hospitals,
Belfast.
Paraganglioma of the head and neck is an
uncommon entity; only twelve such tumours
arising in the nasal mucosa have been reported.
As with all neuroendocrine tumours, it can be
very difficult to predict the biological behaviour
of these lesions. We describe a case of nasal
paraganglioma and discuss the utility of
immunohistochemistry inprognosticevaluation.
A twenty-four year old male presented with
unilateralnasalobstructionandepistaxis;anterior
rhinoscopy revealed the presence of a vascular
polypoid lesion high in the left nasal cavity.
Following resection by lateral rhinotomy,
histologydemonstratedaneuroendocrinetumour
consisting of chief cells arranged in zellballen,
surrounded by S100-positive sustentacular cells
consistent with a paraganglioma; electron
microscopy provided supportive ultrastructural
evidence.
Paragangliomata may exhibit cytological atypia
and mitotic activity but the vast majority are
clinically benign - only four malignant variants
have been described. Since morphology alone
cannot be used as the sole determinant of
benignity,S100andKi-67immunohistochemistry
have become a valuable adjunct; the presence of
S100-positive sustentacular cells surrounding
nests ofchiefcells is areassuring feature. In the
present case, Ki-67 immunoreactivity was
demonstratedin 18%ofthetumourcells,agreater
state of cellular proliferation than one might
expect in a benign lesion. Although numerous
sustentacularcellswerealsoidentified,thedegree
ofcellularproliferation is worrying and suggests
a high potential for local recurrence.
Although paragangliomata can provide both
diagnostic and prognostic difficulties,
immunohistochemistry is a useful adjunct to
routine histology and can reinforce the need for
vigilant follow-up.
ROLE OF NESTED POLYMERASE CHAIN
REACTION FOR DETECTION OF
RESPIRATORY PATHOGENS IN CHILDREN
WITH BRONCHITIS.
G M Ong, P V Coyle, D E Wyatt, H J O'Neill, C
McCaughey
RegionalVirusLaboratory, RoyalHospitalTrust,Belfast.
InfluenzaA(H3N2)andrespiratorysyncytialvirus
(RSV) co-circulated during the wintermonths of
November 1999 - January 2000. Nested
polymerasechainreaction(nPCR)wascompared
with immunofluorescence (IF) for the detection
of RSV serotype A and B in children with
suspected bronchiolitis. Coinfection with
influenza A(H3N2), Chlamydia spp. and
enterovirus/rhinoviruswasalsoinvestigatedusing
molecular techniques.
Atotalof50nasopharyngealsecretionscollected
from babies with bronchiolitis in the month of
January2000comprisingIFRSVpositive(n=27)
andRSV negative (n=23) specimens were tested
for both RSV serotypes, influenza A(H3N2),
Chlamydia spp. and enterovirus/rhinovirus by
nPCR. All specimens were also negative by IF
for influenza A, influenza B, adenovirus and
parainfluenza virus types 1, 2 and 3.
Twenty-six specimens were positive forRSV by
both methods. Two secretions which were
negative forRSV by IF werepositive forRSV A
and B respectively by nPCR. Chlamydia spp.
(identified as C.trachomatis) was present in one
infant with RSV B andwho gave arecenthistory
of treated C.trachomatis conjunctivitis.
Enterovirus was found in 11/50 secretions of
which 9 were speciated asrhinovirus, 3 hadRSV
orinfluenzaAcoinfection (RSVA=1, RSVB=1,
H3N2=1) detectedbynPCRandonehadRSVby
IF.
nPCRprovedmore sensitive and specific thanIF
in detecting RSV and Influenza A(H3N2). The
presence of influenza A infection in secretions
reportednegative using conventional techniques
highlightsinfectioncontrolissuesinthecohorting
of bronchiolitis patients in hospital. The
demonstration of RSV and C.trachomatis
infection addressed the contribution ofthe latter
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to bronchiolitis and the efficacy of treatment in
eradicating Chlamydia carriage in this child.
CORRELATION BETWEEN SERUM IGA
ANTIENDOMYSIAL ANTIBODY AND
DUODENAL MORPHOLOGY IN COELIAC
DISEASE.
A L Bane, N Bermingham, R McLoughlin, A
Whelan, D O'B Hourihane
DepartmentofHistopathologyandImmunology,StJames's
Hospital & Trinity College, Dublin.
The objective of this study was to correlate the
serumIgAantiendomysialantibody(EmA) status
and titre with the severity of the small bowel
enteropathy as assessed by light microscopy.
Three groups of twelve patients were reviewed
retrospectively; all patients had a diagnosis of
small bowel enteropathy by light microscopy.
Group 1 had apositive serumIgAEmA, Group 2
had a weak positive serum IgA EmA and Group
3hadanegative serumIgAEmA. Repeatbiopsies
together with contemporaneous IgA EmAs and
clinical details were reviewed.
The degree of enteropathy as assessed by villus
cryptratio,intraepitheliallymphocytecount(IEL)
andinflammatory infiltrate in the laminapropria
was most severe in the Group 1 patients and
declined progressively through Group 2 and 3.
This was statistically significant with regards to
the mean villus crypt ratio, p=0.0007 (Mann
WhitneyUtest) andthemeanIELcount,p=0.049
(Student t test). The titre ofEmA also correlated
positivelywiththeseverityofenteropathy.Repeat
duodenal biopsy, on agluten free diet confirmed
the presence ofimproved duodenal morphology.
Similarly theEmA statusrevertedtothenegative
in the previously positive group.
In conclusion the presence and titre of EmA
correlatespositivelywiththeseverityofthesmall
bowel enteropathy in Coeliac disease but is not
100% sensitive for its diagnosis.
MANTLE CELL IYMPHOMA PRESENTING AS A
BREAST MASS
Dr P Windrum,1 Dr T C M Morris,' Dr M A
Catherwood,1 Dr H D Alexander,' Dr D T
McManus,2 Dr G M Markey.1
1. Haematology Department, Belfast City Hospital.
2. Histopathology Department, Belfast, City Hospital.
Breastlymphomaaccountsforlessthan 1% ofall
non-Hodgkin's lymphoma (NHL) and
approximately0.1%ofallbreastneoplasms. Most
breast lymphomas are classified as diffuse large
B-cell or MALT lymphomas according to the
REAL classification.
A case of a 53 year old lady presenting with a
breast mass and found to have aperipheral blood
(PB) lymphocytosis is described. Core biopsy of
the breastlesion showed aB-cell NHL, probably
oflarge-celltypeandofhighgrade. Morphologic
and immunohistochemical analysis of PB and
bone marrow (BM) suggested a mantle cell
lymphoma (MCL). The diagnosis of MCL and
theclonaloriginofthelymphomawasconfirmed
by detection oft(l1;14) in BM and breast tissue
by polymerase chain reaction (PCR) analysis.
The patient received six cycles of CHOP
chemotherapy following which there was no
evidence of the lesion on mammography but
residual disease remained in the bone marrow
trephine biopsy. In view of this the patient
proceeded to high dose chemotherapy with
autologous peripheral blood stem cell
transplantation. Subsequent BM trephine biopsy
examinations have shown evidence of residual
disease after transplantation.
To our knowledge there have been no previous
reports ofconfirmed MCLpresenting as abreast
mass. As adiagnosis ofMCLhastherapeutic and
prognosticimplications forthepatient, cyclinDl
immunohistochemistry and PCR analysis are
necessary for its diagnosis. Haematologists and
pathologists should also be aware that MCL can
present in this way.
TRENDS IN BACTERAEMIA ON THE
HAEMATOLOGY AND ONCOLOGY UNITS IN A
UK TERTIARY REFERRAL HOSPITAL, 1994/5,
1998/9 AND 1999/00
Jugo J, Crowe M J, Rooney P J. Belfast City Hospital
Bacteriology Laboratory, Belfast Link Laboratories,
Belfast.
This is aretrospective study ofbacteriologically
confirmed bacteraemia/fungaemia on the
haematology and oncology units at Belfast City
HospitalTrust(BCHT)betweenSeptember 1994
andAugust 1995, andSeptember 1998 andAugust
2000lookingattrendsinaetiology andsensitivity
profiles. BCHT is atertiary referral hospital with
an 11 bedhaematology unit and an oncology unit
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that has increased in size from 10 beds in 1994/5
to 18 beds in 1999. The trends inbacteraemia are
consistent with the findings of the European
Organisation for Research and Treatment of
Cancer (EORTC) trials.' Coagulase negative
staphylococci (CNS)andEscherichiacoliremain
theleadingcausesofmonomicrobialbacteraemia
on both the haematology and oncology units. On
the haematology unit enterococci have emerged
as an important cause of monomicrobial and
polymicrobial bacteraemia increasing from one
isolate in 1994/5 to 14 isolates in 1999/00.
Stenotrophomonas maltophilia together with
other non fermenting Gram negative rods are an
increasingly common cause of bacteraemia on
the haematology unit.
There were no isolates ofglycopeptide resistant
enterococci (GRE) or methicillin resistant
Staphylococcus aureus (MRSA) in blood on the
oncologyunit. GREwerefirstisolatedfromblood
on the haematology unit in 1997 and between
September 1998 and August 2000 nine of 25
(36%) enterococcal isolates in seven patients on
thehaematologyunitwereglycopeptideresistant.
During the same time period three of 19 (16%)
isolates ofStaphylococcus aureusinbloodonthe
haematologyunitweremethicillinresistant. Only
one of 50 isolates ofE. coli from both units was
resistant to ciprofloxacin.
1. Klastersky, J. Scienceandpragmatisminthetreatment
andprevention ofneutropenic infection. JAntimicrob
Chemother 1998; 41: Suppl. D, 13-24.
SOFT TISSUE SARCOMAS - THE BELFAST
EXPERIENCE
M Scott,' R I Davis,' R J Barr 2
1. Departments ofPathology, RoyalGroupofHospitals,
Belfast.
2. Orthopaedic Surgery, Royal Group of Hospitals,
Belfast.
Softtissuesarcomastendtobedifficulttomanage
due to their multitudinous anatomical sites with
localrecurrence presenting aparticularproblem.
Given the rarity of these tumours,
multidisciplinary management by specialist
orthopaedicandplasticsurgeons,radiotherapists,
oncologists and pathologists is necessary for
optimalresults. TherecentUKCCCRmeeting on
soft tissue sarcomas indicated that too many
surgeons from various specialties are dealing
with these tumours. We decided to both quantify
the number of soft tissue sarcomas diagnosed in
Belfast over a twelve-year period (1988 to 1999
inclusive) and to ascertain which surgical
specialties have excised these tumours.
The histopathology reports of all patients with
soft tissue sarcomas diagnosed in Belfast during
the aforementioned period were retrospectively
reviewed with regard to the tumour type and the
referring specialty. Two hundred and thirty-four
soft tissue sarcomas of 19 different histological
types were treated by 35 individual surgeons
from 9 specialties. Ninety-four tumours (40.2%)
were excised by surgeons in disciplines other
than orthopaedic or plastic surgery; 87 cases
(37.1%)wereoperatedonbyorthopaedicsurgeons
and 53 cases (22.7%) were managed by plastic
surgeons. Since the establishment of a sarcoma
team in Northern Ireland in the mid- 1990s, the
proportion of tumours excised by non-sarcoma
specialists has halved, falling from 50% in 1995
to 24% in 1999.
Too many soft tissue sarcomas are still being
managed by non-specialists. All surgeons in
Northern Ireland and throughout the UK should
be aware of the need for centralisation of soft
tissue sarcoma management.
MOLECULAR DETECTION OF THE T(2;5)
TRANSLOCATION BY REVERSE
TRANSCRIPTASE-POLYMERASE CHAIN
REACTION
M A Catherwood, H D Alexander, T C M Morris
Haematology Department, Belfast City Hospital, Lisburn
Road, Belfast.
Anaplasticlargecelllymphoma(ALCL)is ahigh
gradelymphomawhichusuallyshowsexpression
ofthe Ki-1 (CD30) antigen and the presence ofa
specific translocation t(2;5)(p23;q35) which
involvesthegenescodingnucleophosmin(NPM),
a non-ribosomal nucleolar phosphoprotein on
chromosome 5 and a novel tyrosine specific
proteinkinasecalledanaplasticlymphomakinase
(ALK).
This translocation leads to the production of a
NPM/ALK fusion mRNA and protein. The
presenceoftheproducts ofthefusiongenecanbe
detected by reverse transcriptase-polymerase
chainreaction (RT-PCR). Thet(2;5) has notbeen
describedinnon-haematolymphoid malignancies
using classical cytogenetics.
C) The Ulster Medical Society, 2001.70 The UlsterMedical Journal
Methodologically, molecular demonstration of
the t(2;5) is problematical. RT-PCR is used to
amplify the NPM/ALK chimeric message which
is difficult to detect when RNA is extracted from
formaldehyde-fixed paraffin embedded tissue.
Paraffin section immunohistochemistry on a
lymph node from the left side of neck showed
tumour cells staining with T cell antibodies and
CD30. StainingforCD20wasnegativeandCD15
focal. Total RNA was extracted from
formaldehyde-fixedparaffinwaxembeddedtissue
biopsies using a guanidinium thiocyanate based
method. RT-PCR was performed using
oligonucleotide primers specific for chimeric
mRNA encoding for the fused NPM/ALK
transcript.
The presence of a NPM/ALK chimeric message
was demonstrated using the method described.
This approach shouldprovide areliablemeansof
confirmingt(2;5)inequivocalcases.Recognition
ofthisNPM/ALKtranscriptisbothdiagnostically
and prognostically significant since t(2;5) cases
of ALCL represent a group of good prognosis
neoplasms.
HOTSPOT MICROVESSEL COUNT, PLATELET
COUNT AND PLASMA VASCULAR
ENDOTHELIAL GROWTH FACTOR IN NON-
SMALL CELL LUNG CARCINOMA
K Mulholland,' A N J Graham,2 P Maxwell,'
G Spence,2 K G McManus,2 J A McGuigan,2
H Bharuchal
1. Department ofPathology.
2. Department of Thoracic Surgery Royal Group of
Hospitals Trust, Belfast BT12 6BA.
The aim of this project was to evaluate the
prognostic significance of, and any possible
correlation between MVC, plasma vascular
endothelial growth factor (VEGF) and platelet
count in patients with non-small cell carcinoma.
Thepatientcohortstudiedconsistedof47patients
whohadresectionofnon-smallcellcarcinomaof
thelung.Microvesselcountswereevaluatedusing
the "vascular hotspots" technique, interactive
digital analysis and anti CD34 antibody. Plasma
VEGF and the peripheral blood platelet count
were measured pre-operatively. The median
follow-up was 18 months.
There was apositive correlation between plasma
VEGFlevels andtheplateletcounts.VEGFlevels
and platelet counts were inversely related to
cancer-free survival. Raised microvessel counts
suggested a poor prognosis but the findings did
not reach statistical significance.
PRIMARY ADENOCARCINOMA ARISING FROM
AN ILEOSTOMY
A Stockman, J Patterson, K Khosraviani, R
Maxwell, M Y Walsh
Dept. of Pathology and Colorectal Unit, Royal Victoria
Hospital, Belfast.
Adenocarcinoma arising from an ileostomy site
is rare with only 30 cases previously reported.
A69-year-oldfemalepresentedin 1999tosurgical
outpatientswithasixmonthhistoryofableeding
lesionatthevergeofherstoma.Shehadundergone
panproctocolectomy in 1965 for familial
adenomatouspolyposis (FAP). Localexcisionof
the lesion was performed and histological
examination revealed a well-differentiated
adenocarcinoma.
The first such case was reported in 1969, and the
mean interval between ileostomy formation and
diagnosis of adenocarcinoma is 24.5 years. All
the cases have been associated with FAP,
ulcerative colitis or Crohn's disease.
Thepathogenesisofanileostomyadenocarcinoma
is speculative. A feature present in many of the
previous reported cases is colonic metaplasia of
the ileostomy mucosa, and it is often postulated
that this potentiates malignant degeneration of
the stoma via either the dysplasia-carcinoma or
adenoma-carcinoma sequence.
The lesion excised in this case was stained using
high iron diamine-alcian blue and showed no
evidence of black-staining sulfomucins which
are only present in large bowel mucosa. This
suggested that the tumour was of small bowel
phenotype and did not arise on a background of
colonic metaplasia.
Regardless of the pathogenesis, the clinical
implications are that patients with longstanding
ileostomies are at a small risk of developing
stomal tumours, and with a long latency period
the incidence is likely to increase.
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HER-2/NEU OVER EXPRESSION IN BREAST
CARCINOMA: QUANTIFICATION AND
CORRELATION WITH OTHER PROGNOSTIC
VARIABLES.
C Brodie, E Jones, M Griffin, S O'Briain
Department ofPathology, St James's Hospital, Dublin 8.
Her-2/neu is a transmembrane receptor the
overexpression of which is an independent
indicator ofpoor prognosis in breast carcinoma.
Recently anti-Her-2 antibody has become
available for therapeutic use in Her-2 positive
tumours.
The purpose of this study was to evaluate the
level of Her-2/neu overexpression in breast
carcinoma andtocorrelate itwithotherroutinely
measured prognostic indicators.
A series of 80 cases of primary invasive breast
carcinoma was immunohistochemically tested
for Her-2/neu overexpression (Herceptest,TM
DAKO). Also analysed were the patients' age,
tumourtype,tumoursize,tumourgrade,oestrogen
and progesterone receptor status.
17 (21%) showed strong positive (3+) staining
for Her-2/neu; a further 10 (12%) showed weak
positive(2+)stainingandtheremaining53(66%)
were negative. 9/17 (53%) of tumours showing
strong positive staining were oestrogen receptor
(ER) negative as opposed to 21/80 (27%) in the
entire series. 5/17 (29%) were grade 3 tumours
and 3/17 (18%) were grade 1 tumours, compared
to 22% and 30% respectively for the series. The
mean tumour size (29 mm) and the mean patient
age (59 years) were essentially similar in Her-2/
neu positive and negative cases.
Her-2/neu status is found to be an independent
variable in breast carcinoma which correlates
negatively with ER status. Positive Her-2/neu
staining is associated with high tumour grade to
a less pronounced extent. No relationship was
found between Her-2/neu overexpression and
either tumour size or patient age.
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